Back

Delaying cefiderocol resistance development in NDM-producing Enterobacter cloacae complex by combining cefiderocol with aztreonam in vitro.

Goepel, L.; Tran Thanh, T.; Tran Nguyen, M. T.; Hauswaldt, S.; Nur Canbulat, O.; Rupp, J.; Boutin, S.; Nurjadi, D.

2024-02-13 microbiology
10.1101/2024.02.13.579981 bioRxiv
Show abstract

BackgroundThe rapid development of cefiderocol resistance poses a significant concern, particularly in Enterobacterales that produce New Delhi metallo-{beta}-lactamase (NDM). This study explores the potential of inhibiting the development of cefiderocol resistance by combining cefiderocol with aztreonam. MethodsA resistance induction experiment using 20 clinical isolates was performed to assess the impact of cefiderocol-aztreonam on preventing cefiderocol resistance development at 4x and 10x cefiderocol MIC, with and without aztreonam (2, 4, 8 {micro}g/ml). Additionally, serial passaging with doubling cefiderocol concentrations was performed with and without aztreonam. Whole genome sequencing (WGS) was performed to identify potential genetic factors associated with the phenotype. ResultsAmong the 20 E. cloacae complex isolates, 40% (8/20) exhibited a significant reduction in cefiderocol MIC ([≥]4-fold MIC reduction) in the presence of 4 {micro}g/ml aztreonam. Combining cefiderocol with a fixed concentration of 4 {micro}g/ml aztreonam inhibited cefiderocol resistance development in these eight isolates at an inoculum of 107 cfu/ml. Additional resistance induction experiments through serial passaging indicated a delayed emergence of cefiderocol-resistant clones when cefiderocol was combined with aztreonam. WGS analysis revealed a significant positive association between blaCTX-M-15, blaOXA-1, and other co-localized genes with a substantial MIC reduction for cefiderocol-aztreonam compared to cefiderocol alone. ConclusionOur study suggested that cefiderocol resistance development in NDM-producing E. cloacae complex can be delayed or inhibited by combining cefiderocol with aztreonam, even in the presence of multiple {beta}-lactamase genes. A MIC reduction of at least 4-fold emerges as the most reliable predictor for inhibiting resistance development with this dual {beta}-lactam combination.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.1%
22.9%
2
Journal of Antimicrobial Chemotherapy
43 papers in training set
Top 0.1%
19.0%
3
Antibiotics
32 papers in training set
Top 0.2%
6.9%
4
Journal of Global Antimicrobial Resistance
15 papers in training set
Top 0.1%
6.9%
50% of probability mass above
5
PLOS ONE
4510 papers in training set
Top 25%
6.9%
6
JAC-Antimicrobial Resistance
13 papers in training set
Top 0.1%
4.0%
7
International Journal of Antimicrobial Agents
15 papers in training set
Top 0.1%
3.7%
8
Journal of Clinical Microbiology
120 papers in training set
Top 0.8%
1.9%
9
Journal of Medical Microbiology
20 papers in training set
Top 0.2%
1.9%
10
Journal of Applied Microbiology
18 papers in training set
Top 0.1%
1.8%
11
Microbiology
57 papers in training set
Top 0.5%
1.7%
12
Scientific Reports
3102 papers in training set
Top 57%
1.7%
13
Microbiology Spectrum
435 papers in training set
Top 3%
1.7%
14
mSystems
361 papers in training set
Top 5%
1.5%
15
Microbial Genomics
204 papers in training set
Top 2%
1.1%
16
BMC Microbiology
35 papers in training set
Top 1%
1.0%
17
Access Microbiology
22 papers in training set
Top 0.5%
0.9%
18
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.8%
19
Biomedicines
66 papers in training set
Top 4%
0.5%
20
Cureus
67 papers in training set
Top 6%
0.5%
21
Applied and Environmental Microbiology
301 papers in training set
Top 4%
0.5%
22
MicrobiologyOpen
18 papers in training set
Top 0.4%
0.5%
23
mSphere
281 papers in training set
Top 7%
0.5%
24
Frontiers in Microbiology
375 papers in training set
Top 11%
0.5%
25
BMC Infectious Diseases
118 papers in training set
Top 6%
0.5%